The present invention relates to compounds of formula I ##STR00001## wherein A, G and R.sup.1 to R.sup.3 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.

 
Web www.patentalert.com

< 19-nor-vitamin D analogs with 3,2-dihydrofuran ring

> Indolylmaleimide derivatives as PKC inhibitors

> Activator for peroxisome proliferator-activated receptor .delta.

~ 00574